TRANSPHORM INC (TGAN) Stock Analyst Ratings
NASDAQ:TGAN - Nasdaq - US89386L1008 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to TGAN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.66. This target is 11% above the current price.
TGAN was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about TGAN.
In the previous month the buy percentage consensus was at a similar level.
TGAN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-16 | Benchmark | Downgrade | Buy -> Hold |
| 2023-10-13 | Benchmark | Maintains | Buy -> Buy |
| 2023-08-15 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-15 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2023-06-28 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2022-08-16 | Benchmark | Maintains | Buy |
| 2022-06-15 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2022-05-25 | B. Riley Securities | Maintains | Buy |